The M13 phage’s special abilities involved a set of proteins displayed on the tip of the virus, called GP3. NPT088 uses GP3 proteins. NeuroPhage’s lead candidate, NPT088 is a differentiated drug ...

The researchers tested this opportunity with the M13 phage, a filamentous virus 1000 nanometres long but only 5 nanometres wide (one nanometre is one-billionth of a metre).

This in vivo experiment demonstrates the safety and effectiveness of a combined engineered M13 phage-GET-IL-12 cancer vaccine. It produced an effective anti-tumor immune response, ...

Unlike some other types of phage, M13 does not carry genes for toxins. It has a long record of being innocuous to humans, and in NeuroPhage’s hands, as well, experiments in some 300 aged transgenic ...